Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Affibody and Creative Antibiotics to collaborate on targeted antibiotics

Feb. 3, 2012

Eusa Pharma acquires Asparec rights

Feb. 2, 2012

Impax Pharmaceuticals gains U.S. rights to migraine therapy

Feb. 2, 2012

Shire and Sangamo BioSciences enter agreement for hemophilia therapeutics

Feb. 2, 2012

Astellas and UCB sign Japanese development and commercialization agreement for Cimzia

Feb. 1, 2012

Spectrum Pharmaceuticals in-licenses long-acting granulocyte colony-stimulating factor

Feb. 1, 2012

Takeda returns Posidur rights to Durect

Jan. 31, 2012

Orexo ends collaboration with Janssen

Jan. 31, 2012

Servier and Monash University establish GPCR collaboration

Jan. 31, 2012

Navidea Biopharmaceuticals enters into agreement for Parkinson's disease imaging agent

Jan. 30, 2012

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...